Skip to content

PlGF/sFlt-1 and outcomes in CKD

PlGF/sFlt-1 and outcomes in CKD - PlGF/sFlt-1 and outcomes

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000031900
Enrollment
1351
Registered
2018-03-27
Start date
2004-04-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

CKD

Interventions

None listed

Sponsors

Nara Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: CKD criteria defined as an eGFR less than 60 mL/min or continuous proteinuria over 3 months

Exclusion criteria

Exclusion criteria: acute coronary syndrome within 3 months malignancy within 5 years acute kidney injury pregnancy

Design outcomes

Primary

MeasureTime frame
cardiovascuar events renal outcomes including end staging renal disease renal anemia all-cause mortality cancer incidence

Countries

Japan

Contacts

Public ContactMasaru Matsui

Nara Medical University Nephrology

matsui-o-v2008420@olive.plala.or.jp0744-22-3051

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026